Tag: Prostate cancer

Prostate cancer has a reputation as an older man's diagnosis, yet a growing number of men in their 20s, 30s, and 40s are hearing it too. Inherited gene mutations, missed early symptoms, and lifestyle factors all feed the trend, and younger patients often face later-stage disease. Early PSA testing paired with MRI offers a powerful way to catch trouble sooner. keep reading

For decades, doctors treated testosterone as the enemy of the prostate, a hormone to be cut off at all costs. The science now tells a far more nuanced story. Testosterone does not turn healthy prostate cells cancerous, and for men living with low testosterone, replacement therapy turns out to be both safe and effective when guided by proper testing. keep reading

As many as 75% of PSA tests come back falsely positive, and for years that single number sent men straight to a needle biopsy with all its risks. Today, noninvasive biomarker tests in blood and urine, paired with mpMRI, are reshaping who truly needs the procedure and who can safely be spared the discomfort and the worry. keep reading

Does a vasectomy cause prostate cancer? Will treatment inevitably ruin your sex life? Can changing your diet cure the disease outright? Myths like these spread fast and worry men needlessly. Here is a measured, evidence-based look at five of the most common, plus the focal-therapy perspective that so many popular discussions quietly leave out. keep reading

Could saying "I do" actually help a man live longer? When it comes to prostate cancer, the research is surprisingly consistent across decades. Married patients tend to be diagnosed earlier and survive longer than their unmarried peers, and new data now suggests the protective effect of marriage may extend to lowering cancer risk in the first place. keep reading

Your prostate has a secret line of defense that scientists only just discovered. Specialized immune cells called T cells travel to the prostate and stay there for months or years, standing guard against infection. Now researchers believe the same process that protects mouse prostates may apply to humans, and it could open a new door in prostate cancer treatment. keep reading

Focal therapy destroys a prostate tumor while leaving healthy tissue intact. But once treatment is done, how do doctors know if it worked? A structured follow-up protocol using mpMRI is the current standard. Now a newly proposed PSMA-based scoring system called PSMA-FAB is aiming to complement that approach. keep reading

What if the very cells meant to protect your body are being hijacked to shield a tumor? In metastatic prostate cancer, that's exactly what can happen. Researchers are now launching a clinical trial to test whether combining radiation with targeted immune drugs can break through this defense and potentially point the way toward a cure. keep reading

A prostate MRI can detect cancer without contrast but how confident can a doctor be? DCE-MRI adds a third layer of information by capturing tumor blood flow patterns that plain MRI can't show. Gadolinium makes this possible, and modern formulations have an impressive safety record: over 170 million doses studied. keep reading

A high PSA result sounds alarming but it doesn't automatically mean cancer. Other factors can raise PSA, and until recently, the only way to know more was a biopsy. Now, two major breakthroughs are reshaping prostate cancer screening in ways that protect men from unnecessary procedures. keep reading